| SARS-CoV-2 Omicron variant neutralization in serum from vaccinated and convalescent persons A Rössler, L Riepler, D Bante, D von Laer, J Kimpel New England Journal of Medicine 386 (7), 698-700, 2022 | 427 | 2022 |
| SARS-CoV-2 3CLpro mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376 E Heilmann, F Costacurta, SA Moghadasi, C Ye, M Pavan, D Bassani, ... Science translational medicine 15 (678), eabq7360, 2022 | 96 | 2022 |
| BA. 2 and BA. 5 omicron differ immunologically from both BA. 1 omicron and pre-omicron variants A Rössler, A Netzl, L Knabl, H Schäfer, SH Wilks, D Bante, ... Nature communications 13 (1), 7701, 2022 | 70 | 2022 |
| Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: the pragmatic, multi-center, three-arm, partially randomized … Z Bánki, J Mateus, A Rössler, H Schäfer, D Bante, L Riepler, A Grifoni, ... EBioMedicine 80, 2022 | 33 | 2022 |
| Six-Month Follow-Up of Immune Responses after a Rapid Mass Vaccination against SARS-CoV-2 with BNT162b2 in the District of Schwaz/Austria Z Bánki, L Seekircher, B Falkensammer, D Bante, H Schäfer, T Harthaller, ... Viruses 14 (8), 1642, 2022 | 4 | 2022 |
| Seroprevalence of SARS-CoV-2 infection in the Tyrolean district of Schwaz at the time of the rapid mass vaccination in March 2021 following B. 1.351-variant outbreak P Willeit, J Kimpel, H Winner, T Harthaller, H Schäfer, D Bante, ... Frontiers in Public Health 10, 989337, 2022 | 3 | 2022 |
| Immune response to 2-dose BNT162b2 vaccination and risk of SARS-CoV-2 breakthrough infection: The Shieldvacc-2 study L Seekircher, Z Bánki, J Kimpel, A Rössler, H Schäfer, B Falkensammer, ... medRxiv, 2022.04. 19.22273872, 2022 | 3 | 2022 |
| SARS-CoV-2 B. 1.1. 529 variant (Omicron) evades neutralization by sera from vaccinated and convalescent individuals. medRxiv [Internet]. 2021 Dec 11 [cited 2021 Dec 15]; 2021 … A Roessler, L Riepler, D Bante, D Laer, J Kimpel | 3 | |
| High Prevalence of Undocumented SARS-CoV-2 Infections in the Pediatric Population of the Tyrolean District of Schwaz T Harthaller, W Borena, D Bante, H Schäfer, O Strallhofer, T Zöggeler, ... Viruses 14 (10), 2294, 2022 | 2 | 2022 |
| Retained avidity despite reduced cross-binding and cross-neutralizing antibody levels to Omicron after SARS-COV-2 wild-type infection or mRNA double vaccination T Harthaller, B Falkensammer, D Bante, M Huber, M Schmitt, ... Frontiers in Immunology 14, 1196988, 2023 | 1 | 2023 |
| Durability of Cross-Neutralizing Antibodies 5.5 Months After Bivalent Coronavirus Disease 2019 Vaccine Booster A Rössler, L Knabl, A Netzl, D Bante, W Borena, D von Laer, DJ Smith, ... The Journal of Infectious Diseases 229 (3), 644-647, 2024 | | 2024 |
| BA. 2 omicron differs immunologically from both BA. 1 omicron and pre-omicron variants A Rössler, A Netzl, L Knabl, H Schäfer, SH Wilks, D Bante, ... medRxiv, 2022.05. 10.22274906, 2022 | | 2022 |
